Literature DB >> 30062605

Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy?

Luca Giovanella1, Anca M Avram2, Jerome Clerc3, Elif Hindié4, David Taïeb5, Frederik A Verburg6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30062605     DOI： 10.1007/s00259-018-4110-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  24 in total

1.  Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.

Authors:  Tae Yong Kim; Won Bae Kim; Eun Sook Kim; Jin Sook Ryu; Jeong Seok Yeo; Seong Chul Kim; Suck Joon Hong; Young Kee Shong
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

2.  Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.

Authors:  Karen A Heemstra; Ying Y Liu; Marcel Stokkel; Job Kievit; Eleonora Corssmit; Alberto M Pereira; Johannes A Romijn; Johannes W A Smit
Journal:  Clin Endocrinol (Oxf)       Date:  2007-01       Impact factor: 3.478

3.  Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging?

Authors:  Anca M Avram; Lorraine M Fig; Kirk A Frey; Milton D Gross; Ka Kit Wong
Journal:  J Clin Endocrinol Metab       Date:  2013-02-21       Impact factor: 5.958

4.  SERIAL NECK ULTRASOUND IS MORE LIKELY TO IDENTIFY FALSE-POSITIVE ABNORMALITIES THAN CLINICALLY SIGNIFICANT DISEASE IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS.

Authors:  Samantha Peiling Yang; Ariadne M Bach; R Michael Tuttle; Stephanie A Fish
Journal:  Endocr Pract       Date:  2015-09-15       Impact factor: 3.443

5.  Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial.

Authors:  Martin Schlumberger; Sophie Leboulleux; Bogdan Catargi; Desiree Deandreis; Slimane Zerdoud; Stephane Bardet; Daniela Rusu; Yann Godbert; Camille Buffet; Claire Schvartz; Pierre Vera; Olivier Morel; Danielle Benisvy; Claire Bournaud; Marie-Elisabeth Toubert; Antony Kelly; Ellen Benhamou; Isabelle Borget
Journal:  Lancet Diabetes Endocrinol       Date:  2018-05-26       Impact factor: 32.069

6.  Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.

Authors:  Alon Vaisman; Steven Orlov; Jonathan Yip; Cindy Hu; Terence Lim; Mark Dowar; Jeremy L Freeman; Paul G Walfish
Journal:  Head Neck       Date:  2010-06       Impact factor: 3.147

7.  Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients.

Authors:  E Robenshtok; S Fish; A Bach; Jose M Domínguez; A Shaha; R M Tuttle
Journal:  J Clin Endocrinol Metab       Date:  2012-05-25       Impact factor: 5.958

Review 8.  Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges.

Authors:  Luca Giovanella; Ulla Feldt-Rasmussen; Frederik A Verburg; Stephan K Grebe; Mario Plebani; Penelope M Clark
Journal:  Clin Chem Lab Med       Date:  2015-08       Impact factor: 3.694

9.  Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survival.

Authors:  Arnoldo Piccardo; Federico Arecco; Matteo Puntoni; Luca Foppiani; Manlio Cabria; Stefania Corvisieri; Anselmo Arlandini; Vania Altrinetti; Roberto Bandelloni; Fabio Orlandi
Journal:  Clin Nucl Med       Date:  2013-01       Impact factor: 7.794

10.  Short-term Follow-up US Leads to Higher False-positive Results Without Detection of Structural Recurrences in PTMC.

Authors:  Jung Hyun Yoon; Hye Sun Lee; Eun-Kyung Kim; Ji Hyun Youk; Hyun Gi Kim; Hee Jung Moon; Jin Young Kwak
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
View more
  1 in total

1.  99mTc-Pertechnetate Scintigraphy Predicts Successful Postoperative Ablation in Differentiated Thyroid Carcinoma Patients Treated with Low Radioiodine Activities.

Authors:  Luca Giovanella; Gaetano Paone; Teresa Ruberto; Luca Ceriani; Pierpaolo Trimboli
Journal:  Endocrinol Metab (Seoul)       Date:  2019-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.